TBPH NASDAQ
Theravance Biopharma Inc
1W: +0.1%
1M: +0.0%
3M: -3.4%
YTD: -6.2%
1Y: +21.2%
3Y: +88.0%
5Y: +139.5%
$17.03
Last traded 2026-09-25 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$104M
Revenue
+35.1% YoY
$54M
Net Income
+312.9% YoY
$52M
Free Cash Flow
-78.8% YoY
93.0%
Gross Margin
-2.9%
Op. Margin
-28.5%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE20.9%
ROA12.0%
ROIC-7.2%
Valuation
P/E16.0
P/B3.0
EV/EBITDA7.7
Leverage
Debt/Equity0.13
Current Ratio13.54
Interest Cov.55.6x
Quality Scores
Piotroski F7/9
Altman Z1.99
Beneish M-2.69